-
2025-523586-18-00
5
Non-Small Cell Lung Cancer
-
2025-523202-32-00
5
2026-02-26
Major Depressive Disorder
-
2023-507031-38-00
5
2023-01-09
Severe viral lung infections
-
2024-516066-11-00
5
2022-08-31
Patients with newly diagnosed, histologically confirmed, primary advan
-
2024-520290-12-00
6
2025-11-04
Hormone receptor–positive (HRpos)/human epidermal growth factor recept
-
2025-520473-40-00
4
2025-09-29
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
-
2024-517458-90-00
5
2025-06-06
Chronic obstructive pulmonary disease (COPD)
-
2024-516173-76-01
5
2025-04-22
HER2-positive or HER2-low (incl. ultra-low) early breast cancer
-
2023-504904-26-00
5
2025-04-07
Progressive Pulmonary Fibrosis
-
2023-508076-11-00
5
2025-04-01
Colon cancer staged T3-4 and/or nodal positive by CT and/or MRI scan w
-
2023-508429-29-00
4
2024-09-26
Progressive Pulmonary Fibrosis
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-506150-21-00
4
2024-05-29
Celiac Disease
-
2023-504322-19-00
5
2024-01-10
Patients in the intensive care unit on ventilation with pneumonia and
-
2023-503349-71-00
4
2023-10-30
Pancreatodudoenectomy
-
2024-511219-78-00
5
2023-02-28
epithelial ovarian cancer
-
2022-500764-35-00
6
2022-10-13
Patients with advanced HER2-negative, hormone receptor positive (HER2n
-
2024-512174-10-00
5
2021-11-11
metastatic colorectal cancer
-
2024-513723-16-00
4
2021-10-21
metastatic colorectal cancer
-
2022-502954-15-00
4
2024-06-21
Idiopathic pulmonary fibrosis
-
2023-508085-15-00
5
2024-05-15
Chronic Obstructive Pulmonary Disease
-
2023-504471-25-00
5
2024-03-01
Fibrotic Lung Disease
-
2024-513091-17-00
5
2021-09-29
Progressive myopia
-
2023-507961-24-00
5
2021-04-19
High-Risk HER2-Positive Breast Cancer